Nilda Mesa - 24 Jul 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4
Filing time
28 Jul 2025, 06:26:19 UTC
Previous filing
25 Jun 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mesa Nilda Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 25 Jul 2025 0001756697

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +590 +12% $0.000000 5,473 25 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Units Options Exercise $0 -590 -100% $0.000000 0 25 Jul 2025 Common Stock 590 $0.000000 Direct F1, F2
transaction UTHR Restricted Stock Units Award $0 +650 $0.000000 650 24 Jul 2025 Common Stock 650 $0.000000 Direct F2, F3, F4
transaction UTHR Stock Options Award $0 +1,830 $0.000000 1,830 24 Jul 2025 Common Stock 1,830 $306.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2 Not applicable as restricted stock units do not have an expiration date.
F3 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F4 Annual non-employee director award.